Brian Goff
Vermogen: 7 M $ op 30-09-2026
Vermogen: 7 M $ op 30-09-2026
Brian M. Goff is lid van de raad van bestuur van Pathways to College Network en Chief Commercial, Global Operations Officer & EVP bij Alexion Pharmaceuticals, Inc. De heer Goff was eerder Chief Operating Officer & Director bij Neurovance, Inc., Head-Global Hemophilia Franchise bij Baxter Healthcare Corp., Executive Vice President & President-Hematology bij Baxalta, Inc. en VP, Head-Primary Care & Established medicines bij Novartis Pharmaceuticals Corp. De heer Goff behaalde een doctoraal aan Skidmore College en een MBA aan The Wharton School van de Universiteit van Pennsylvania.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-06-2026 | 184.508 ( 0,31% ) | 6 M $ | 30-09-2026 | |
| 09-06-2026 | 32.609 ( 0,02% ) | 393 265 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Algemeen Directeur | 08-08-2022 |
| INTELLIA THERAPEUTICS, INC. | Directeur/Bestuurslid | 13-06-2024 |
Pathways to College Network | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Operationeel Directeur | 21-07-2021 |
| BAXALTA INC | Corporate Officer/Principal | 01-07-2016 |
| IDENIX PHARMACEUTICALS INC | Directeur/Bestuurslid | 15-05-2012 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Corporate Officer/Principal | - |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Operationeel Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and other infectious diseases caused by hepatitis and human immunodeficiency virus | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Commercial Services |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Skidmore College
Skidmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Pathways to College Network | |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau